CBRS is trading 11% down at $201.80 after its first quarterly earnings report as a public company highlighted a disappointing margin outlook and cautious 2026 guidance.
- While the company reported strong revenue growth and a sizeable backlog supported by a major OpenAI deal, investors are focused on downward pressure on margins.
- Shares continue to sell off in pre-market trading as the market reassesses the company's valuation following the June 23 earnings release.
- The cautious long-term guidance has overshadowed current growth metrics, leading to concerns regarding the firm's path to profitability.